PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 35 filers reported holding PROFOUND MED CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,352 | -52.7% | 21,309 | -39.6% | 0.00% | – |
| Q2 2023 | $459,174 | +203.2% | 35,294 | +116.5% | 0.00% | – |
| Q1 2023 | $151,427 | +1.5% | 16,300 | +19.0% | 0.00% | – |
| Q4 2022 | $149,193 | -33.1% | 13,700 | -75.2% | 0.00% | – |
| Q3 2022 | $223,000 | -42.4% | 55,200 | +4.0% | 0.00% | – |
| Q2 2022 | $387,000 | -17.8% | 53,100 | +1.5% | 0.00% | – |
| Q1 2022 | $471,000 | -70.7% | 52,300 | -63.4% | 0.00% | – |
| Q4 2021 | $1,605,000 | -35.9% | 142,943 | -16.5% | 0.00% | – |
| Q3 2021 | $2,504,000 | +65.3% | 171,108 | +84.7% | 0.00% | – |
| Q2 2021 | $1,515,000 | -50.7% | 92,647 | -39.3% | 0.00% | – |
| Q1 2021 | $3,076,000 | +87.6% | 152,713 | +91.4% | 0.00% | – |
| Q4 2020 | $1,640,000 | +302.9% | 79,775 | +245.6% | 0.00% | – |
| Q3 2020 | $407,000 | +117.6% | 23,083 | +20.0% | 0.00% | – |
| Q1 2020 | $187,000 | – | 19,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 341,767 | $7,029,000 | 13.80% |
| GAGNON SECURITIES LLC | 821,196 | $16,883,000 | 2.69% |
| Gagnon Advisors, LLC | 277,252 | $5,700,000 | 2.56% |
| Taylor Wealth Management Partners | 166,294 | $3,419,000 | 1.32% |
| PCJ Investment Counsel Ltd. | 126,930 | $2,611,000 | 1.22% |
| EAM Global Investors LLC | 172,291 | $3,542,000 | 0.96% |
| AWM Investment Company, Inc. | 348,939 | $7,174,000 | 0.91% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $16,048,000 | 0.58% |
| Wealth Management Partners, LLC | 20,282 | $554,000 | 0.43% |
| Parkman Healthcare Partners LLC | 69,049 | $1,420,000 | 0.36% |